{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:28:56Z","timestamp":1785364136647,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,16]]},"DOI":"10.7759\/cureus.28073","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T19:27:06Z","timestamp":1660678026000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Invasive Pulmonary Aspergillosis vs. Pulmonary Aspergilloma in Immunocompromised Patient With Preexisting Lung Cavity"],"prefix":"10.7759","author":[{"given":"John","family":"Pueringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirzari K","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Aspergilloma","author":"Chakraborty RK","year":"2022","unstructured":"Chakraborty RK, Baradhi KM. Aspergilloma. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00001011","article-title":"Pulmonary aspergillosis: a clinical review","volume":"20","author":"Kousha M","year":"2011","unstructured":"Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011, 20:156-174. 10.1183\/09059180.00001011","journal-title":"Eur Respir Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning DW","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, et al.. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016, 47:45-68. 10.1183\/13993003.00583-2015","journal-title":"Eur Respir J"},{"key":"ref4","unstructured":"Subacute invasive pulmonary aspergillosis. (2022). Accessed. August 8, 2022: https:\/\/radiopaedia.org\/articles\/subacute-invasive-pulmonary-aspergillosis?lang=us."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24 Suppl 1","author":"Ullmann AJ","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al.. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018, 24 Suppl 1:e1-e38. 10.1016\/j.cmi.2018.01.002","journal-title":"Clin Microbiol Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3201\/eid2408.171312","article-title":"Case definition of chronic pulmonary Aspergillosis in resource-constrained settings","volume":"24","author":"Denning DW","year":"2018","unstructured":"Denning DW, Page ID, Chakaya J, et al.. Case definition of chronic pulmonary Aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018, 24:10.3201\/eid2408.171312","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-007-0460-4","article-title":"Lung cavities, mycetomas and hemoptysis","volume":"157","author":"Domej W","year":"2007","unstructured":"Domej W, Hermann J, Krause R, Wehrsch\u00fctz M, Maier A, Fl\u00f6gel E. Lung cavities, mycetomas and hemoptysis. Wien Med Wochenschr. 2007, 157:466-472. 10.1007\/s10354-007-0460-4","journal-title":"Wien Med Wochenschr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2012.04.001","article-title":"Pulmonary aspergilloma: clinical aspects and surgical treatment outcome","volume":"22","author":"Passera E","year":"2012","unstructured":"Passera E, Rizzi A, Robustellini M, Rossi G, Della Pona C, Massera F, Rocco G. Pulmonary aspergilloma: clinical aspects and surgical treatment outcome. Thorac Surg Clin. 2012, 22:345-361. 10.1016\/j.thorsurg.2012.04.001","journal-title":"Thorac Surg Clin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.40.1195","article-title":"Expression of vascular endothelial growth factor in pulmonary aspergilloma","volume":"40","author":"Inoue K","year":"2001","unstructured":"Inoue K, Matsuyama W, Hashiguchi T, et al.. Expression of vascular endothelial growth factor in pulmonary aspergilloma. Intern Med. 2001, 40:1195-1199. 10.2169\/internalmedicine.40.1195","journal-title":"Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/thx.7.4.317","article-title":"Broncho-pulmonary aspergillosis","volume":"7","author":"Hinson KF","year":"1952","unstructured":"Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis. Thorax. 1952, 7:317-333. 10.1136\/thx.7.4.317","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200936","article-title":"'Monod' and 'air crescent' sign in aspergilloma","volume":"2013","author":"Sharma S","year":"2013","unstructured":"Sharma S, Dubey SK, Kumar N, Sundriyal D. 'Monod' and 'air crescent' sign in aspergilloma. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-200936","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00005382-199209000-00009","article-title":"The spectrum of pulmonary aspergillosis","volume":"7","author":"Gefter WB","year":"1992","unstructured":"Gefter WB. The spectrum of pulmonary aspergillosis. J Thorac Imaging. 1992, 7:56-74. 10.1097\/00005382-199209000-00009","journal-title":"J Thorac Imaging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly JP","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al.. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020, 71:1367-1376. 10.1093\/cid\/ciz1008","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer CD","year":"2006","unstructured":"Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006, 42:1417-1427. 10.1086\/503427","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.1.299-305.2005","article-title":"Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan","volume":"43","author":"Pazos C","year":"2005","unstructured":"Pazos C, Pont\u00f3n J, Del Palacio A. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol. 2005, 43:299-305. 10.1128\/JCM.43.1.299-305.2005","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89455-7","article-title":"The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis","volume":"100","author":"Horvath JA","year":"1996","unstructured":"Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med. 1996, 100:171-178. 10.1016\/S0002-9343(97)89455-7","journal-title":"Am J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70263-H","article-title":"Itraconazole therapy in aspergillosis: Study in 49 patients","volume":"23","author":"Dupont B","year":"1990","unstructured":"Dupont B. Itraconazole therapy in aspergillosis: Study in 49 patients. J Am Acad Dermatol. 1990, 23:607-614. 10.1016\/0190-9622(90)70263-H","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S12714","article-title":"Update on the optimal use of voriconazole for invasive fungal infections","volume":"4","author":"Lat A","year":"2011","unstructured":"Lat A, Thompson GR 3rd. Update on the optimal use of voriconazole for invasive fungal infections. Infect Drug Resist. 2011, 4:43-53. 10.2147\/IDR.S12714","journal-title":"Infect Drug Resist"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000489474","article-title":"Treatment of chronic pulmonary aspergillosis: current standards and future perspectives","volume":"96","author":"Alastruey-Izquierdo A","year":"2018","unstructured":"Alastruey-Izquierdo A, Cadranel J, Flick H, et al.. Treatment of chronic pulmonary aspergillosis: current standards and future perspectives. Respiration. 2018, 96:159-170. 10.1159\/000489474","journal-title":"Respiration"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1086\/367933","article-title":"Voriconazole: a new triazole antifungal agent","volume":"36","author":"Johnson LB","year":"2003","unstructured":"Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003, 36:630-637. 10.1086\/367933","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783x-16-4-139","article-title":"Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature","volume":"16","author":"Sandherr M","year":"2011","unstructured":"Sandherr M, Maschmeyer G. Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature. Eur J Med Res. 2011, 16:139-144. 10.1186\/2047-783x-16-4-139","journal-title":"Eur J Med Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: a clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon W","year":"2019","unstructured":"Byon W, Garonzik S, Boyd RA, Frost CE. Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet. 2019, 58:1265-1279. 10.1007\/s40262-019-00775-z","journal-title":"Clin Pharmacokinet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101209-a-case-of-invasive-pulmonary-aspergillosis-vs-pulmonary-aspergilloma-in-immunocompromised-patient-with-preexisting-lung-cavity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:34Z","timestamp":1707507514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101209-a-case-of-invasive-pulmonary-aspergillosis-vs-pulmonary-aspergilloma-in-immunocompromised-patient-with-preexisting-lung-cavity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.28073","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}